| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |